OOIR: Observatory of International Research

Papers

(The H4-Index of Diabetic Medicine is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Diabetes and COVID‐19: psychosocial consequences of the COVID‐19 pandemic in people with diabetes in Denmark—what characterizes people with high levels of COVID‐19‐related worries?	135
COVID‐19 and diabetes	113
Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID‐19 pandemic	74
Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus	60
Predictors of type 2 diabetes remission in the Diabetes Remission Clinical Trial (DiRECT)	53
Dexamethasone therapy in COVID‐19 patients: implications and guidance for the management of blood glucose in people with and without diabetes	49
The SARS‐CoV‐2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: A multi‐centre study of the first COVID‐19 wave	44
Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta‐analysis of randomised controlled trials	41
The impact of the COVID‐19 pandemic on people with diabetes and diabetes services: A pan‐European survey of diabetes specialist nurses undertaken by the Foundation of European Nurses in Diabetes surve	41
Assessment of the effect of the COVID‐19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring	40
The management of diabetic ketoacidosis in adults—An updated guideline from the Joint British Diabetes Society for Inpatient Care	40
At multiple fronts: Diabetes stigma and weight stigma in adults with type 2 diabetes	37
Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID‐19 pandemic	35
Meta‐analyses of randomized controlled trials reporting the effect of home foot temperature monitoring, patient education or offloading footwear on the incidence of diabetes‐related foot ulcers	33
Impact of the COVID‐19 pandemic and lockdown restrictions on psychosocial and behavioural outcomes among Australian adults with type 2 diabetes: Findings from the PREDICT cohort study	33
Time in range: A best practice guide for UK diabetes healthcare professionals in the context of the COVID‐19 global pandemic	32
Guidelines for the management of diabetes services and patients during the COVID‐19 pandemic	32
Real‐world evidence on clinical outcomes of people with type 1 diabetes using open‐source and commercial automated insulin dosing systems: A systematic review	32
Dietary pattern, colonic microbiota and immunometabolism interaction: new frontiers for diabetes mellitus and related disorders	31
The bidirectional longitudinal association between depressive symptoms and HbA_1c: A systematic review and meta‐analysis	30
Acute hyperglycaemic crisis after vaccination against COVID‐19: A case series	30
Effects of mindfulness‐ and acceptance‐based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta‐analysis	30
Developmental programming by maternal obesity: Lessons from animal models	30
Managing People with Diabetes Fasting for Ramadan During the COVID‐19 Pandemic: A South Asian Health Foundation Update	28
Approaches to screening for hyperglycaemia in pregnant women during and after the COVID‐19 pandemic	27

International comparison of glycaemic control in people with type 1 diabetes: an update and extension	27
Guidelines for the management of diabetes in care homes during the Covid‐19 pandemic	26